Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Rekombinanter AZI2 Antikörper

Der Kaninchen Monoklonal anti-AZI2 Antikörper (Klon 30A13) (ABIN7879852) detektiert spezifisch AZI2 in WB, IF und ICC. Dieser Antikörper reagiert spezifisch mit Proben aus Human, Ratte und Maus.
Produktnummer ABIN7879852
644,88 €
Zzgl. Versandkosten 20,00 € und MwSt
100 μL
Lieferung nach: Deutschland
Lieferung in 6 bis 9 Werktagen

Kurzübersicht für Rekombinanter AZI2 Antikörper (ABIN7879852)

Target

Alle AZI2 Antikörper anzeigen
AZI2 (5-Azacytidine Induced 2 (AZI2))

Antikörpertyp

Recombinant Antibody

Reaktivität

  • 45
  • 34
  • 33
  • 4
  • 3
  • 3
  • 2
  • 2
  • 2
  • 1
Human, Ratte, Maus

Wirt

  • 46
Kaninchen

Klonalität

  • 25
  • 21
Monoklonal

Konjugat

  • 17
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 1
Dieser AZI2 Antikörper ist unkonjugiert

Applikation

  • 33
  • 24
  • 21
  • 10
  • 6
  • 1
  • 1
  • 1
Western Blotting (WB), Immunofluorescence (IF), Immunocytochemistry (ICC)

Klon

30A13
  • Verwendungszweck

    AZI2 Antibody / 5-Azacytidine-induced protein 2

    Aufreinigung

    Affinity-chromatography

    Immunogen

    A synthesized peptide derived from human TAF3 was used as the immunogen for the AZI2 antibody.

    Isotyp

    IgG
  • Applikationshinweise

    Optimal dilution of the AZI2 antibody should be determined by the researcher.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Liquid

    Buffer

    Rabbit IgG in phosphate buffered saline, pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol, 0.4-0.5 mg/mL BSA

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Lagerung

    -20 °C

    Informationen zur Lagerung

    Store the AZI2 antibody at -20oC.
  • Target

    AZI2 (5-Azacytidine Induced 2 (AZI2))

    Andere Bezeichnung

    AZI2

    Hintergrund

    AZI2 antibody is designed to detect 5-azacytidine-induced protein 2, also known as NAP1 or TBK1-binding protein 1. AZI2 is a cytoplasmic protein that plays a significant role in innate immunity by regulating signaling pathways that activate interferon regulatory factors (IRFs) and nuclear factor kappa B (NF-kB). Through its interactions with kinases such as TBK1 and IKKe, AZI2 contributes to the activation of interferon-stimulated genes and inflammatory mediators that defend the host against viral and bacterial infections.

    AZI2 antibody has become a valuable reagent for immunology and virology research. The protein is induced in response to 5-azacytidine and is involved in noncanonical NF-kB signaling. It is known to function in concert with NAP1, facilitating the recruitment of kinases that phosphorylate IRF3 and IRF7, leading to interferon beta production. Detecting AZI2 expression and localization provides insight into how innate immune responses are initiated and regulated at the molecular level.

    Applications of AZI2 antibody include western blotting, immunohistochemistry, immunofluorescence, and flow cytometry. In western blot assays, AZI2 antibody identifies the protein with specificity, allowing researchers to monitor expression in cells exposed to pathogens or immune modulators. In immunohistochemistry, it reveals tissue-specific distribution patterns, while immunofluorescence highlights cytoplasmic localization and colocalization with signaling proteins. These applications make AZI2 antibody versatile for dissecting immune signaling pathways in diverse research contexts.

    AZI2 is particularly important in antiviral defense. Studies have demonstrated that AZI2 participates in signaling cascades activated by Toll-like receptors (TLRs) and RIG-I-like receptors (RLRs), key components of pathogen recognition. Altered AZI2 expression can impair interferon responses, contributing to viral persistence or inadequate immune control. By using AZI2 antibody, researchers can track changes in expression that correlate with immune activation and disease outcomes.

    In addition to innate immunity, AZI2 has been implicated in cancer biology and inflammation. Dysregulation of NF-kB and interferon pathways is common in tumor microenvironments, where chronic inflammation promotes cancer progression. Monitoring AZI2 expression with specific antibodies supports studies aimed at understanding how immune signaling intersects with oncogenesis.

    AZI2 antibody from NSJ Bioreagents provides researchers with a dependable reagent to study innate immunity, viral infection, and NF-kB signaling. Its proven specificity across assay platforms ensures accurate detection, supporting investigations into host defense and immune regulation.

    UniProt

    Q9H6S1
Sie sind hier:
Chat with us!